Skip to Main Content

Paper Details

The efficacy of trastuzumab-deruxtecan for the treatment of patients with advanced HER2-low breast cancer.
Expert Rev Anticancer Ther
0
2023
Author NameAffiliation
Sara M TolaneyDana-Farber Cancer Institute
  • 1 - 1

Datasets

Release 1.2